Back to search

272bio Limited

12062536

active
Private Limited Company
england wales
Companies House
Health Score
78 / 100

Some Concerns

30/30
Filing
10/30
Financial
38/40
Risk
  • Current liabilities exceed current assets (-10)
  • 1 outstanding charge (-2)

Details

THE GATEWAY BUILDING COLLEGIATE SQUARE, READING, RG2 9LH
Incorporated 21/06/2019

Compliance

Last accounts

30/06/2025

total exemption full

Next accounts due

31/03/2027

On track

Confirmation statement

Last: 24/08/2025

Due 07/09/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Charles Edward Owen

director · Since 21/06/2019

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 59

Also on 7 other boards

Mrs Lizbeth Anne Littlewood

director · Since 03/01/2023

DIRECTOR

BRITISH · ENGLAND · Age 53

Also on 1 other board

Thomas William Roderick Hayward

director · Since 22/12/2023

DIRECTOR

BRITISH · ENGLAND · Age 53

Dr Juerg Baggenstoss

director · Since 10/07/2024

DIRECTOR

SWISS · SWITZERLAND · Age 48

Ms Christine Labeur

director · Since 13/09/2024

COMPANY DIRECTOR

BELGIAN · BELGIUM · Age 65

Persons with Significant Control

Dr Charles Edward Owen

Significant control

British · England · Age 59

The Gateway Building, Collegiate Square, Reading, RG2 9LH

Notified 21/06/2019

Charges1 outstanding

Charge
outstanding

HSBC UK BANK PLC

Created 16/04/2021Registered 21/04/2021

CompanyRankvs 201+ SIC 72110 peers
71

Financial strength96th percentile among SIC peers · 24/25
Employees97th percentile among SIC peers · 15/15
LiquidityCurrent ratio 2.29× · 20/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
201272bio Limited
80
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/06/2025

Net Worth

£2.5M

Balance sheet strength

Cash

£814k

Cash in the bank

Net Current Assets

£1.2M

Working capital

Current Assets

£2.2M

Current Liabilities

£960k

Fixed Assets

£1.6M

Debtors

£1.4M

21avg. employees+7

Tax at Year End(2021)

Corp tax£16k

Balance Sheet

Intangible assets£6k
Assets less current liabilities£2.8M
Signed by Dr C Owen Mr T Hayward 7th August 2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20252.29-£1.1M
20243.39+£3.2M
20231.68-£570k
20222.97+£725k
20212.35+£89k
20205.89—

Derived from filed accounts. Not audited figures.